2771 - 2780 of 7877 Results
Title
Year
-
OPENTitle: Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III StudiesJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 7Start Page: 781End Page: 794Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-021-00826-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-021-00826-9.pdfCitation Count: 11
-
OPENTitle: Genetic diversity of axon degenerative mechanisms in models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 155Issue #:Start Page: 105368End Page: 105368Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105368Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105368Citation Count: 18
-
OPENTitle: Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia—The SPASTOX TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1733End Page: 1733Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28659Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28659Citation Count: 1
-
OPENTitle: LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 103Issue #:Start Page: 142.e1End Page: 142.e5Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.02.018Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178224Citation Count: 16
-
RESTRICTEDTitle: Managing Advanced Parkinson DiseaseJournal Name: Journal of Geriatric Psychiatry and NeurologyPublisher: SAGE PublicationsVol: 34Issue #: 4Start Page: 289End Page: 300Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/08919887211018277Citation Count: 6
-
OPENTitle: Measuring Patient Preferences at the FDA Center for Devices and Radiological Health: Reflections and ProjectionsJournal Name: Value in HealthPublisher: Elsevier BVVol: 24Issue #: 7Start Page: 1024End Page: 1029Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.jval.2021.01.009Best OA location URL: http://www.valueinhealthjournal.com/article/S109830152100139X/pdfCitation Count: 1
-
RESTRICTEDTitle: Parkinson disease-associated cognitive impairmentJournal Name: Nature Reviews Disease PrimersPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41572-021-00280-3Best OA location URL: https://www.nature.com/articles/s41572-021-00280-3.pdfCitation Count: 392
-
RESTRICTEDTitle: Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participantsJournal Name: BMJ OpenPublisher: BMJVol: 11Issue #: 7Start Page: e046329End Page: e046329Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/bmjopen-2020-046329Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/11/7/e046329.full.pdfCitation Count: 18
-
RESTRICTEDTitle: Progress towards therapies for disease modification in Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 7Start Page: 559End Page: 572Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00061-2Best OA location URL: https://discovery.ucl.ac.uk/10130306/1/Foltynie_Disease%20Modifying%20reviewVersion4_ML2_CLEAN.pdfCitation Count: 157
-
RESTRICTEDTitle: Should we start integrating genetic data in decision-making on device-aided therapies in Parkinson disease? A point of viewJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 88Issue #:Start Page: 51End Page: 57Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.05.013Citation Count: 16